Center for Advanced Microbiome Research and Innovation’s MD/PhD Graduate from UMSOM Medical School
Madeline (Maddy) Alizadeh, MD, PhD, a graduate of the MD/PhD Program at the University of Maryland School of Medicine (UMSOM) and the Center for Advanced Microbiome Research and Innovation (CAMRI) at the Institute for Genome Sciences (IGS), has matched to the Internal Medicine residency program at NYU Grossman School of Medicine. She will join the highly competitive Clinical Investigator Track, which integrates dedicated research time into residency training.
Dr. Alizadeh completed her PhD in the lab of Jacques Ravel, PhD, within CAMRI at IGS, where her dissertation, “Exploring the role of the intestinal microbiome in IBD-associated arthritis,” focused on uncovering how the gut microbiome contributes to extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) through multi-omics approaches. She was also co-mentored by Dr. Erik Von Rosenvinge, a gastroenterologist at UMSOM. During her PhD, she demonstrated exceptional scholarly productivity, authoring more than 20 peer-reviewed publications.
Match Day 2026: Dr. Alizadeh matched to NYU Grossman School of Medicine Internal Medicine in the Clinical Investigator Track.
Dr. Alizadeh completed her PhD in the lab of Jacques Ravel, PhD, within CAMRI at IGS, where her dissertation, “Exploring the role of the intestinal microbiome in IBD-associated arthritis,” focused on uncovering how the gut microbiome contributes to extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) through multi-omics approaches. She was also co-mentored by Dr. Erik Von Rosenvinge, a gastroenterologist at UMSOM. During her PhD, she demonstrated exceptional scholarly productivity, authoring more than 20 peer-reviewed publications.
“I’m incredibly excited to continue building on my PhD work during residency,” Dr. Alizadeh said. “The Clinical Investigator Track at NYU provides a unique opportunity to integrate clinical training with research, allowing me to further study the multi-omics of EIMs of IBD while preparing for a research-focused gastroenterology fellowship.”
The Clinical Investigator Track is designed to support physician-scientists by providing protected research time throughout internal medicine training. This will enable Dr. Alizadeh to continue advancing her work at the intersection of microbiome science and inflammatory disease.
“Maddy’s match to NYU’s Clinical Investigator Track is a testament to her exceptional accomplishments as both a clinician and a scientist,” said her mentor, Jacques Ravel, PhD. “Her PhD work was rigorous and highly innovative, and her remarkable publication record reflects both her productivity and her impact in the field. This next phase will position her to translate her findings into meaningful advances in patient care.”
Dr. Ravel and Dr. Alizadeh at the 2026 Student Awards Ceremony & Dinner on May 12, 2026.
During her training at UMSOM, Dr. Alizadeh was recognized for both her academic excellence and her commitment to compassionate patient care. On May 12, during the UMSOM Student Awards Ceremony, she received the Louis, Ida, and Samuel Cohen Award for Personal Attributes of Scholarship, Ability, and Compassion for Patients from the Department of Medicine, as well as the Robley Dunglinson Award for Excellence in Preventive Medicine from the Department of Epidemiology and Public Health, further recognition of her outstanding contributions to patient care. Dr. Alizadeh officially graduated from the University of Maryland School of Medicine during the commencement ceremony held on May 14.
MD graduation, May 14, 2026. Dr. Alizadeh with Dr. Erik Von Rosenvinge and Dr. Jacques Ravel, her PhD co-mentors.
Reflecting on her time at CAMRI and IGS, Dr. Alizadeh emphasized the importance of interdisciplinary training. “My experience at CAMRI provided a strong foundation in microbiome research and multi-omics,” she said. “Combining this with clinical training has shaped how I think about complex diseases and how we can better understand and treat them.”
Dr. Alizadeh plans to pursue a career in gastroenterology with a focus on inflammatory bowel disease, aiming to bridge mechanistic research and clinical care to improve outcomes for patients with complex inflammatory conditions.